P1197: axicabtagene ciloleucel (axi-cel) in combination with rituximab for the treatment of relapsed/refractory (r/r) large b-cell lymphoma (lbcl): outcomes of the phase 2 zuma-14 study
HemaSphere(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要